A Man with a Recurrent Left Pleural Effusion In late 2020, a new disease entity that was referred to as VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was reported. Q: What is the cause of VEXAS syndrome?A: VEXAS syndrome is caused by somatic mutations in UBA1 (the gene that encodes ubiquitin-like modifier activating enzyme 1), which initiates […]
IRVINE, California, March 2, 2022, Genomic Testing Cooperative, LCA (GTC) announced today that their hematology molecular profiling is expanded to cover analysis of the UBA1 and NFE2 genes. Both genes were recently reported to be clinically important for the diagnosis and treatment of patients with hematologic neoplasms. Recently described VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, […]
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap clinically. Using machine learning, we developed an approach to stratify patients with DLBCL into four subgroups based on survival characteristics. This approach uses data from the targeted transcriptome to predict […]
Posters at ASH21 In partnership with Anthology Diagnostics and Key Genomics, GTC presented four abstracts at ASH 2021 GTC’s posters from 2021 Convention of American Society of Hematology are now available to be downloaded. Please reach out with any questions. Download Poster Download Poster Download Poster Download Poster Read more Articles and News from GTC
Irvine, California– December 1, 2021 – Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the annual American Society of Hematology (ASH) meeting new data on the use of their proprietary machine learning approaches in the diagnosis of acute graft-versus-host disease (aGVHD) and for the stratifying of patients with diffuse large B-cell […]
GTC is excited to be exhibiting at ASH for the first time and look forward to meeting people in person. Our booth # 3440 and would like you will stop by and say hello. If you would like to schedule a meeting fill out the form below We have four abstracts being presented at ASH – here is […]
Irvine, CA – June 30th – Genomic Testing Cooperative, a first-in-class diagnostic company based on a cooperative business model (Co-Op) using the most recent advances in NGS technology, announced today a collaboration with Elevation Oncology to enhance identification of patients with any solid tumor harboring an NRG1 fusion who may be eligible for enrollment in […]
Irvine, California– June 23, 2021 – Genomic Testing Cooperative, LCA (GTC) announced that the New York State Clinical Evaluation Program (CLEP) has completed their evaluation and approved all GTC’s Next Generation Sequencing (NGS) profiling tests for hematologic neoplasms and solid tumors. This includes: -GTC Hematology Profile (177 genes)-GTC Hematology Fusion/Expression (1408 genes)-GTC Hematology PLUS (177 […]
New on-site laboratory called Key Genomics is a partnership between Regional Cancer Care Associates (RCCA) and Genomic Testing Cooperative (GTC), provides more precise testing to help improve cancer patient outcomes HACKENSACK, N.J. AND IRVINE, C.A., May 4, 2021 —Patients at John Theurer Cancer Center at Hackensack University Medical Center now have access to state-of-the-art genomic […]
EDISON, N.J. AND IRVINE, C.A. (March 16, 2021) — Hackensack Meridian Health and Genomic Testing Cooperative (GTC) in Irvine, California, have teamed up to establish the first-of-its-kind genomic profiling laboratory called Anthology Diagnostics, to generate more personalized, precise, and real-time insights for cancer patients, oncologists and hospitals. The reference laboratory located at Hackensack Meridian JFK University Medical […]